Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia.
Huang QS, Wang JZ, Qin YZ, Zeng QZ, Jiang Q, Jiang H, Lu J, Liu HX, Liu Y, Wang JB, Su L, Zhang HY, Li ZL, Gao SJ, Huang B, Liu YY, Liu YR, Xu LP, Huang XJ, Zhang XH.
Huang QS, et al. Among authors: liu hx, liu yy, liu y, liu yr.
Blood Adv. 2019 Nov 12;3(21):3406-3418. doi: 10.1182/bloodadvances.2019000564.
Blood Adv. 2019.
PMID: 31714962
Free PMC article.